BRIEF published on 09/15/2026 at 09:35, 2 days 13 hours ago Diagnostic Medical Systems is holding a webinar for investors Financial Results Investors Webinar Perspectives Diagnostic Medical Systems
BRIEF published on 09/14/2026 at 17:55, 3 days 4 hours ago Diagnostic Medical reports a positive net profit for the first half of 2026. EBITDA Net Profit Medical Diagnosis Bone Densitometry #Imaging 2027
BRIEF published on 09/14/2026 at 17:50, 3 days 5 hours ago Diagnostic Medical announces a return to profitability in the first half of 2026 EBITDA Net Result Medical Diagnosis Radiology Bone Densitometry
BRIEF published on 09/08/2026 at 11:05, 9 days 11 hours ago DMS Group Webinar: Information for Shareholders Financial Results Shareholders Investors Webinar DMS Group
BRIEF published on 09/03/2026 at 17:50, 14 days 5 hours ago Diagnostic Medical Systems: Voting Rights Information as of August 31, 2026 Voting Rights Actions Euronext Growth Financial Transparency Diagnostic Medical Systems
BRIEF published on 08/18/2026 at 17:50, 30 days 5 hours ago Diagnostic Medical Systems: Voting rights and shares as of July 31, 2026 Share Capital Voting Rights Actions Euronext Growth DMS Group
BRIEF published on 07/20/2026 at 17:50, 1 month 28 days ago DMS Group Reports Q2 2026 Revenue of €12.2 Million Medical Imaging Geopolitical Impact Q2 2026 Revenue Bones Densitometry Growth Radiology Challenges
BRIEF published on 07/20/2026 at 17:50, 1 month 28 days ago Second quarter 2026 revenue for Diagnostic Medical Systems Revenue DMS Group Radiology Bone Densitometry EIB Financing
PRESS RELEASE published on 07/20/2026 at 17:45, 1 month 28 days ago Q2 2026 REVENUE: EUR 12.2 MILLION Diagnostic Medical Systems (DMS Group) reports Q2 2026 revenue: Radiology down 9%, Bone Densitometry up 32%. 2026 guidance confirms revenue growth. Group aims to outperform medical imaging market Radiology Diagnostic Medical Systems Bone Densitometry Medical Imaging Market Q2 2026 Revenue
BRIEF published on 07/07/2026 at 08:50, 2 months 10 days ago Diagnostic Medical Systems: Capital and Voting Rights Information as of June 30, 2026 Voting Rights Capital Actions Euronext Growth Medical Diagnosis
Published on 09/17/2026 at 22:15, 36 minutes ago Rocky Shore Gold Announces Non-Brokered Private Placement
Published on 09/17/2026 at 22:15, 36 minutes ago Vanta Attends 2026 All-In Summit in Los Angeles, a Leading Gathering of Business, Investment and Industry Leaders
Published on 09/17/2026 at 22:05, 46 minutes ago Loop Industries Forms Strategic Alternatives Committee to Maximize Shareholder Value
Published on 09/17/2026 at 15:55, 6 hours 56 minutes ago Empress Announces Agreement to Acquire Tongon Gold Stream and Secures Debt Financing
Published on 09/17/2026 at 15:25, 7 hours 26 minutes ago AIAI Holdings' Constellation Network Launches Dôr Patient Journey with Proactive MD(R), Expanding Transformational AI In Healthcare
Published on 09/17/2026 at 19:00, 3 hours 51 minutes ago Max Verstappen Passes All 100 Karts in 14 Laps in Red Bull's Max vs 100
Published on 09/17/2026 at 18:58, 3 hours 52 minutes ago EQS-Adhoc: H2APEX Group SCA: General Partner of H2APEX Group SCA resolves to prepare for the transfer of its stock exchange listing from the Regulated Market (Prime Standard) to the Scale segment of the Frankfur
Published on 09/17/2026 at 18:25, 4 hours 26 minutes ago Magentic raises $18M to build the AI workforce for the physical world
Published on 09/17/2026 at 18:10, 4 hours 41 minutes ago A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4%
Published on 09/17/2026 at 17:46, 5 hours 5 minutes ago RBI categorically denies the allegations of short-seller report
Published on 09/17/2026 at 17:40, 5 hours 11 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 5 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 15 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
